Copy number analysis (GISTIC2)
View Report | There were 493 tumor samples used in this analysis: 28 significant arm-level results, 12 significant focal amplifications, and 18 significant focal deletions were found.

Mutation Analysis (MutSig v2.0)
View Report | 

Mutation Analysis (MutSig vS2N)
View Report | 

Clustering of copy number data: consensus NMF
View Report | The most robust consensus NMF clustering of 493 samples using the 30 copy number focal regions was identified for k = 3 clusters. We computed the clustering for k = 2 to k = 8 and used the cophenetic correlation coefficient to determine the best solution.

Clustering of Methylation: consensus NMF
View Report | The 2001 most variable methylated genes were selected based on variation. The variation cutoff are set for each tumor type empirically by fitting a bimodal distriution. For genes with multiple methylation probes, we chose the most variable one to represent the gene. Consensus NMF clustering of 283 samples and 2001 genes identified 3 subtypes with the stability of the clustering increasing for k = 2 to k = 8 and the average silhouette width calculation for selecting the robust clusters.

Clustering of RPPA data: consensus NMF
View Report | The most robust consensus NMF clustering of 454 samples using the 150 most variable proteins was identified for k = 3 clusters. We computed the clustering for k = 2 to k = 8 and used the cophenetic correlation coefficient to determine the best solution.

Clustering of RPPA data: consensus hierarchical
View Report | The 150 most variable proteins were selected. Consensus average linkage hierarchical clustering of 454 samples and 150 proteins identified 3 subtypes with the stability of the clustering increasing for k = 2 to k = 8 and the average silhouette width calculation for selecting the robust clusters.

Clustering of mRNA expression: consensus NMF
View Report | The most robust consensus NMF clustering of 72 samples using the 1500 most variable genes was identified for k = 3 clusters. We computed the clustering for k = 2 to k = 8 and used the cophenetic correlation coefficient to determine the best solution.

Clustering of mRNA expression: consensus hierarchical
View Report | The 1500 most variable genes were selected. Consensus average linkage hierarchical clustering of 72 samples and 1500 genes identified 3 subtypes with the stability of the clustering increasing for k = 2 to k = 8 and the average silhouette width calculation for selecting the robust clusters.

Clustering of mRNAseq gene expression: consensus NMF
View Report | The most robust consensus NMF clustering of 469 samples using the 1500 most variable genes was identified for k = 3 clusters. We computed the clustering for k = 2 to k = 8 and used the cophenetic correlation coefficient to determine the best solution.

Clustering of mRNAseq gene expression: consensus hierarchical
View Report | The 1500 most variable genes were selected. Consensus average linkage hierarchical clustering of 469 samples and 1500 genes identified 3 subtypes with the stability of the clustering increasing for k = 2 to k = 8 and the average silhouette width calculation for selecting the robust clusters.

Clustering of miRseq expression: consensus NMF
View Report | We filtered the data to 150 most variable miRs. Consensus NMF clustering of 480 samples and 150 miRs identified 3 subtypes with the stability of the clustering increasing for k = 2 to k = 8 and the average silhouette width calculation for selecting the robust clusters.

Clustering of miRseq expression: consensus hierarchical
View Report | We filtered the data to 150 most variable miRs. Consensus average linkage hierarchical clustering of 480 samples and 150 miRs identified 3 subtypes with the stability of the clustering increasing for k = 2 to k = 8 and the average silhouette width calculation for selecting the robust clusters.

Correlation between copy number variations of arm-level result and selected clinical features
View Report | Testing the association between copy number variation 71 arm-level results and 9 clinical features across 493 patients, 3 significant findings detected with Q value < 0.25.

Correlation between copy number variation genes and selected clinical features
View Report | Testing the association between copy number variation of 30 peak regions and 9 clinical features across 493 patients, 25 significant findings detected with Q value < 0.25.

Correlation between gene methylation status and clinical features
View Report | Testing the association between 17334 genes and 9 clinical features across 263 samples, statistically thresholded by Q value < 0.05, 8 clinical features related to at least one genes.

Correlation between molecular cancer subtypes and selected clinical features
View Report | Testing the association between subtypes identified by 10 different clustering approaches and 9 clinical features across 502 patients, 46 significant findings detected with P value < 0.05.

Correlation between gene mutation status and selected clinical features
View Report | Testing the association between mutation status of 50 genes and 9 clinical features across 293 patients, 2 significant findings detected with Q value < 0.25.

Correlation between RPPA expression and clinical features
View Report | Testing the association between 166 genes and 9 clinical features across 454 samples, statistically thresholded by Q value < 0.05, 7 clinical features related to at least one genes.

Correlation between mRNA expression and clinical features
View Report | Testing the association between 17814 genes and 7 clinical features across 72 samples, statistically thresholded by Q value < 0.05, 5 clinical features related to at least one genes.

Correlation between mRNAseq expression and clinical features
View Report | Testing the association between 18294 genes and 9 clinical features across 469 samples, statistically thresholded by Q value < 0.05, 8 clinical features related to at least one genes.

Correlation between miRseq expression and clinical features
View Report | Testing the association between 471 genes and 9 clinical features across 480 samples, statistically thresholded by Q value < 0.05, 7 clinical features related to at least one genes.

Correlations between copy number and mRNA expression
View Report | The correlation coefficients in 10, 20, 30, 40, 50, 60, 70, 80, 90 percentiles are -0.21832, -0.0867, 0.0089, 0.0926, 0.1695, 0.2409, 0.3176, 0.40086, 0.5043, respectively.

Correlations between copy number and mRNAseq expression
View Report | The correlation coefficients in 10, 20, 30, 40, 50, 60, 70, 80, 90 percentiles are 786, 1601, 2034, 2431, 2844, 3299.2, 3805, 4366, 5095.3, respectively.

Correlation between mRNA expression and DNA methylation
View Report | The top 25 correlated methylation probes per gene are displayed. Total number of matched samples = 263. Number of gene expression samples = 469. Number of methylation samples = 263.

Association of mutation, copy number alteration, and subtype markers with pathways
View Report | There are 26 genes with significant mutation (Q value <= 0.1) and 408 genes with significant copy number alteration (Q value <= 0.25). The identified marker genes (Q value <= 0.01 or within top 2000) are 2000 for subtype 1, 2000 for subtype 2, 2000 for subtype 3. Pathways significantly enriched with these genes (Q value <= 0.01) are identified :

PARADIGM pathway analysis of mRNA expression data
View Report | There were 70 significant pathways identified in this analysis.

PARADIGM pathway analysis of mRNA expression and copy number data
View Report | There were 60 significant pathways identified in this analysis.